| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10612754 | Journal of Controlled Release | 2013 | 8 Pages |
Abstract
A small subset tumor cells, known as tumor initiating cells (TICs) are responsible for tumor recurrence. Targeting drug loaded nanoparticles to CD133 protein expressed on TICs leads to inhibition of tumor recurrence.78
Keywords
Related Topics
Physical Sciences and Engineering
Materials Science
Biomaterials
Authors
Suresh Kumar Swaminathan, Emilie Roger, Udaya Toti, Lin Niu, John R. Ohlfest, Jayanth Panyam,